FDA OKs Consensi for Osteoarthritis Pain and Hypertension FDA OKs Consensi for Osteoarthritis Pain and Hypertension
The FDA has approved a combination of amlodipine besylate and celecoxib (Consensi, Kitov Pharma) for individuals with osteoarthritis pain and hypertension.FDA Approvals
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Rheumatology News Alert Source Type: news
More News: Celebrex | Hypertension | Internal Medicine | Norvasc | Osteoarthritis | Pain | Pharmaceuticals | Rheumatology